Rare diseases
Investigational molecules
Locations
Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalyGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
ItalyA Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma
ItalyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
ItalyA study to evaluate the efficacy and safety of zenagamtide in people with obesity
ItalyEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ItalyA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
ItalyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
ItalyA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
ItalyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
ItalyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
ItalyStudy of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
